These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22772537)

  • 1. New class of sleep drugs may offer a safer night's rest.
    Willyard C
    Nat Med; 2012 Jul; 18(7):996. PubMed ID: 22772537
    [No Abstract]   [Full Text] [Related]  

  • 2. ACS chemical neuroscience molecule spotlight on Suvorexant.
    Hopkins CR
    ACS Chem Neurosci; 2012 Sep; 3(9):647-8. PubMed ID: 23024835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-in-class insomnia drug on the brink of approval nod.
    Osborne R
    Nat Rev Drug Discov; 2013 Jul; 12(7):492-3. PubMed ID: 23812257
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preclinical and clinical results of dual orexin receptor antagonist, suvorexant (BELSOMRA(®)), a novel therapeutic agent for insomnia].
    Tanaka Y; Aoki I; Ishine T; Renger JJ; Winrow CJ; Hisada S
    Nihon Yakurigaku Zasshi; 2016 Jul; 148(1):46-56. PubMed ID: 27430679
    [No Abstract]   [Full Text] [Related]  

  • 5. Suvorexant: something new for sleep?
    Reddy A; Puvvada SC; Kommisetti S; El-Mallakh RS; Lippmann S
    Acta Neuropsychiatr; 2015 Feb; 27(1):53-5. PubMed ID: 25397996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suvorexant: efficacy and safety profile of a dual orexin receptor antagonist in treating insomnia.
    Owen RT
    Drugs Today (Barc); 2016 Jan; 52(1):29-40. PubMed ID: 26937493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of suvorexant.
    Stahl SM
    CNS Spectr; 2016 Jun; 21(3):215-8. PubMed ID: 27322687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suvorexant approved for insomnia.
    Traynor K
    Am J Health Syst Pharm; 2014 Sep; 71(18):1524. PubMed ID: 25174007
    [No Abstract]   [Full Text] [Related]  

  • 9. Suvorexant: a dual orexin receptor antagonist for the treatment of sleep onset and sleep maintenance insomnia.
    Patel KV; Aspesi AV; Evoy KE
    Ann Pharmacother; 2015 Apr; 49(4):477-83. PubMed ID: 25667197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a new thienodiazepine (We-941) on sleep patterns of normal and insomniac subjects.
    Velasco M; Velasco F; Cepeda C; Romo R; Pérez-Toledo MA
    Neuropharmacology; 1981 May; 20(5):461-8. PubMed ID: 7017450
    [No Abstract]   [Full Text] [Related]  

  • 11. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
    Hoyer D; Jacobson LH
    Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant.
    Herring WJ; Snyder E; Budd K; Hutzelmann J; Snavely D; Liu K; Lines C; Roth T; Michelson D
    Neurology; 2012 Dec; 79(23):2265-74. PubMed ID: 23197752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suvorexant for the treatment of insomnia in patients with Alzheimer's disease.
    Hamuro A; Honda M; Wakaura Y
    Aust N Z J Psychiatry; 2018 Feb; 52(2):207-208. PubMed ID: 29237271
    [No Abstract]   [Full Text] [Related]  

  • 14. Suvorexant-Induced Dream Enactment Behavior in Parkinson Disease: A Case Report.
    Tabata H; Kuriyama A; Yamao F; Kitaguchi H; Shindo K
    J Clin Sleep Med; 2017 May; 13(5):759-760. PubMed ID: 28212694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription Drugs Used in Insomnia.
    Dujardin S; Pijpers A; Pevernagie D
    Sleep Med Clin; 2020 Jun; 15(2):133-145. PubMed ID: 32386689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis.
    Kuriyama A; Tabata H
    Sleep Med Rev; 2017 Oct; 35():1-7. PubMed ID: 28365447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual orexin receptor antagonists - promising agents in the treatment of sleep disorders.
    Pałasz A; Lapray D; Peyron C; Rojczyk-Gołębiewska E; Skowronek R; Markowski G; Czajkowska B; Krzystanek M; Wiaderkiewicz R
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):157-68. PubMed ID: 23702225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypocretin antagonists in insomnia treatment and beyond.
    Ruoff C; Cao M; Guilleminault C
    Curr Pharm Des; 2011; 17(15):1476-82. PubMed ID: 21476951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putting addiction to bed.
    Soares C
    Sci Am; 2010 Jul; 303(1):23-4. PubMed ID: 20583657
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemical probes: A shared toolbox.
    Scott AR
    Nature; 2016 May; 533(7602):S60-1. PubMed ID: 27167393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.